Evidence map›Paper›PMID 36210149›Full record

ArticleCurrent topics in membranes2022

TRPV4: Cell type-specific activation, regulation and function in the vertebrate eye.

Luka Lapajne, Christopher N Rudzitis, Brenan Cullimore, Daniel Ryskamp, Monika Lakk, Sarah N Redmon, Oleg Yarishkin, David Krizaj

Open access · greenAbstract read
In one paragraph

Article in Current topics in membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. TRPV4 expression in the renal tubule is necessary for maintaining whole body KAmerican journal of physiology. Renal physiology · 2023
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Luka LapajneDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States; Department of Ophthalmology, University Medical Centre, University of Ljubljana, Ljubljana, Slovenia.
Christopher N RudzitisDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States.
Brenan CullimoreDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States.
Daniel RyskampDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States.
Monika LakkDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States.
Sarah N RedmonDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States.
Oleg YarishkinDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States.
David KrizajDepartment of Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States; Department of Neurobiology, University of Utah, Salt Lake City, UT, United States; Department of Bioengineering, University of Utah, Salt Lake City, UT, United States. Electronic address: david.krizaj@hsc.utah.edu.
University of Utah · USUniversity of Ljubljana · SI

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jun Yang · 2005 to 2026
$14.6M
Replacement of the Flexcell Tension systemR01EY027920 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI DAVID KRIZAJ · 2017 to 2026
$3.5M
Vision Research Training Grant at the University of UtahT32EY024234 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI DAVID KRIZAJ, Monica L Vetter · 2014 to 2026
$2.3M
The role of mechanosensation in the vertebrate retinaR01EY022076 · NEI · UNIVERSITY OF UTAH · PI KRIZAJ, DAVID · 2013 to 2017
$1.9M
Cellular and Molecular Mechanisms that Contribute to Pressure-Induced Retinal Inflammation and PathologyR01EY031817 · NEI · UNIVERSITY OF UTAH · PI KRIZAJ, DAVID · 2021 to 2024
$1.5M
NCATS NIH HHS UL1 TR002538NEI NIH HHS P30 EY014800NEI NIH HHS R01 EY022076NEI NIH HHS R01 EY027920NEI NIH HHS R01 EY031817NEI NIH HHS T32 EY024234
6 · The paper itself

Abstract

The architecture of the vertebrate eye is optimized for efficient delivery and transduction of photons and processing of signaling cascades downstream from phototransduction. The cornea, lens, retina, vasculature, ciliary body, ciliary muscle, iris and sclera have specialized functions in ocular protection, transparency, accommodation, fluid regulation, metabolism and inflammatory signaling, which are required to enable function of the retina-light sensitive tissue in the posterior eye that transmits visual signals to relay centers in the midbrain. This process can be profoundly impacted by non-visual stimuli such as mechanical (tension, compression, shear), thermal, nociceptive, immune and chemical stimuli, which target these eye regions to induce pain and precipitate vision loss in glaucoma, diabetic retinopathy, retinal dystrophies, retinal detachment, cataract, corneal dysfunction, ocular trauma and dry eye disease. TRPV4, a polymodal nonselective cation channel, integrate non-visual inputs with homeostatic and signaling functions of the eye. The TRPV4 gene is expressed in most if not all ocular tissues, which vary widely with respect to the mechanisms of TRPV4 channel activation, modulation, oligomerization, and participation in protein- and lipid interactions. Under- and overactivation of TRPV4 may affect intraocular pressure, maintenance of blood-retina barriers, lens accommodation, neuronal function and neuroinflammation. Because TRPV4 dysregulation precipitates many pathologies across the anterior and posterior eye, the channel could be targeted to mitigate vision loss.

Indexed as

RetinaTRPV Cation ChannelsAnimalsCorneaLipidsVertebratesLipidsTRPV Cation ChannelsCiliary bodyCorneaEyeGlaucomaRetinaTrabecular meshworkTRPV4

Identifiers

PMID36210149
PMCPMC9879314
OpenAlexW4294280839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.